article · Medical Forum Monthly
This study examined immunological and molecular characteristics of gastritis in people living with type 2 diabetes mellitus. Researchers evaluated 138 participants divided across three cohorts: individuals with Helicobacter pylori gastritis and type 2 diabetes, individuals with gastritis without diabetes, and healthy control subjects. The investigation focused on cytokine patterns associated with these combined conditions. The findings revealed that patients suffering from both Helicobacter pylori gastritis and diabetes exhibited notably lower levels of interleukin-10 compared to those with gastritis alone and healthy controls. Conversely, levels of interleukin-18 were significantly elevated in the group with both conditions compared to the gastritis-only group. Furthermore, the decrease in interleukin-10 was found to be inversely correlated with high-sensitivity C-reactive protein levels in these patients.
Helicobacter pylori infection causes gastritis, which frequently co-occurs with metabolic conditions such as type 2 diabetes. Understanding how inflammatory cytokines behave differently when these diseases interact helps clarify the immune response in affected patients. Recognizing distinct immune profiles, such as shifts in interleukin-10 and interleukin-18, aids clinical understanding of inflammation dynamics in diabetic patients suffering from gastric infections.
The abstract does not indicate an application pathway.
AI-generated from the published abstract. Always read the original work before citing.
Objective: To investigate immunological and molecular features of gastritis in individuals with diabetes mellitus.Study Design: Comparative studyPlace and Duration of Study: This study was conducted at the Gastroenterology & Hepatology Teaching Hospital, Medical City, Baqubah Teaching Hospital, and Al-Kazemi Teaching Hospital, Department of Gastroenterology, from 1st January 2024 to 30th April 2024.Methods: A total of 138 participants including 67 H. pylori gastritis with type 2 diabetic (GHp+ve DM) group, 21 with gastritis without diabetes mellitus (G group), and 50 control group.Results: The GHp+ve, diabetes mellitus had reduced levels. Regarding IL-10 in comparison to G and control, IL-18 levels increased in GHp+ve. In addition, discovered GHp+ve diabetes mellitus had lower levels of IL-10 than G (p<0.05). Moreover, found IL-18 more highly expressed in GHp+ve DM than in gastritis (p<0.05).Conclusion: The gastritis by H. pylori infection to type 2 diabetes and shows IL-10 levels reduced in GHp +ve diabetes mellitus contrast with gastritis group and healthy controls and inversely correlated with high-sensitivity C- reactive protein, IL-18 levels raised in GHp +ve.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.60110/medforum.360615
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
